About
Looking for more information?
Contact our responsive and friendly client services team any time.
INVESTOR PRESENTATION - MAYNE PHARMA GROUP LIMITED
MAYNE PHARMA GROUP LIMITED
Health Care
Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010
Read moreMarket Cap
537.30m
Price at Close
$0.32
4w avg. Volume
4.33m
4w avg. Turnover
$1.46m
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| +3.13% | 14 Oct 2020 |
| +3.13% | 14 Oct 2020 |
| -1.54% | 08 Oct 2020 |
| -1.54% | 08 Oct 2020 |
| -1.54% | 08 Oct 2020 |
| -15.79% | 05 Oct 2020 |
| +1.30% | 28 Sep 2020 |
| +1.30% | 28 Sep 2020 |
| +2.67% | 21 Sep 2020 |
| -1.47% | 02 Sep 2020 |
Market Data
Current Price
$0.32
52WK HIGH
$0.595
52WK LOW
$0.195
1YR RETURN
-45.30%
1YR RETURN VS. SECTOR
-67.08%
90 DAY RETURN
-22.89%
ASX RANK
353
/2,008
SECTOR RANK
2
/31
SHARES OUTSTANDING
1.68b
MAYNE PHARMA GROUP LIMITED
Health Care
Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010
Read moreMarket Cap
537.30m
Price at Close
$0.32
4w avg. Volume
4.33m
4w avg. Turnover
$1.46m
ASX:MYX is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia